Surveillance and modification of immunosuppression minimizes BK virus nephropathy

American Journal of Nephrology

Volumn 32, Issue 1, 2010, Pages 10-12

  Bennett, William M ^a   Meyer, Leslie ^a   Ridenour, Jennifer ^a   Batiuk, Thomas D ^a  

^a LEGACY GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

BK nephropathy; BK virus; Immunosuppression; Renal transplant

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ARTICLE; BK VIRUS; BK VIRUS NEPHROPATHY; BLOOD ANALYSIS; CELLULAR IMMUNITY; CLINICAL ASSESSMENT; DIAGNOSTIC KIT; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; FEMALE; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOASSAY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; TREATMENT OUTCOME; URINALYSIS; VIREMIA; VIRUS LOAD; BIOPSY; BLOOD; GRAFT REJECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; KIDNEY; KIDNEY TRANSPLANTATION; PATHOLOGY; POLYOMAVIRUS INFECTION; URINE; VIROLOGY; VIRUS INFECTION;

BIOPSY; BK VIRUS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIRAL LOAD;

EID: 77952314528     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313888     Document Type: Article

References (12)

1. Hariharan S: BK virus nephritis after renal transplantation. Kidney Int 2006;69:655.
2. Nickeleit V, Singh HK, Mihatsch MJ: Latent and productive polyomavirus infections of renal allografts: morphological, clinical, and pathophysiological aspects. Adv Exp Med Biol 2006;577:190.
3. Nickeleit V, Klimkait T, Binet IF, Dalquen P, Del Zenero V, Thiel G, Mihatsch MJ, Hirsch HH: Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000;342:1309.
4. Drachenberg CB, Papadimitriou JC, Hirsch HH, Wali R, Crowder C, Nogueira J, Cangro CB, Mendley S, Milan A, Ramos E: Histo- logical patterns of polyomavirus nephropa-thy: correlation with graft outcome and viral load. Am J Transplant 2004;4:2082.
5. Saad ER, Bresnahan BA, Cohen EP, Lu N, Orentas RJ, Vasudev B, Hariharan S: Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplant 2008;85:850.
6. Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, Lockwood M, Torrence S, Schuessler R, Roby T, Gaudreault-Keener M, Storch GA: Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005;5:582.
7. Faguer S, Hirsch HH, Kamar N, Guilbeau-Frugier C, Ribes D, Guitard J, Esposito L, Cointault O, Modesto A, Lavit M, Mengelle C, Rostaing L: Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transplant Int 2007;20:962.
8. Babel N, Fendt J, Karaivanov S, Bold G, Arnold S, Sefrin A, Lieske E, Hoffzimmer M, Dziubianau M, Bethke N, Meisel C, Grutz G, Reinke P: Sustained BK viruria as an early marker for the development of BKV-associ-ated nephropathy: analysis of 4,128 urine and serum samples. Transplant 2009;88:89.
9. Smith F, Panek R, Kiberd BA: Screening to prevent polyoma virus nephropathy in kidney transplantation: a cost analysis. Am J Transplant 2009;9:2177.
10. Manitpisitkul W, Drachenberg C, Ramos E, Munivenkatappa R, Philosophe B, Klassen D, Haririan A: Maintenance immunosup-pressive agents as risk factors for BK virus nephropathy: a case-control study. Transplant 2009;88:83.
11. Boldorini R, Allegrini S, Miglio U, Paganot-ti A, Veggiani C: Detection, distribution, and pathologic significance of BK virus strains isolated from patients with kidney transplants, with and without polyomavirus-as-sociated nephropathy. Arch Pathol Lab Med 2009;133:766.
12. Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC: BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant 2010; 10:407415.